“It is the unsung hero of the whole thing,” says Giuseppe Ciaramella, who was head of infectious diseases at Moderna from 2014 to 2018. The vaccines, appropriately celebrated as a first for ...

Covid vaccine manufacturer Moderna has completed a new site in the UK, which it says will help prepare the the country against future pandemics. The Moderna Innovation and Technology Centre (MITC ...

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other growth stocks. The market closed last week mostly lower, however, the S&P 500 has been up ...

If you’re on the fence about investing in Moderna, Inc., Kymera Therapeutics or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your ...

Moderna, the biotech company behind one of the original mRNA COVID-19 vaccines, is undergoing an AI-powered workplace transformation. In partnership with OpenAI, Moderna has created thousands of ...

The surface of the SARS-CoV-2 virus is covered in protein spikes (red). Moderna’s messenger RNA (mRNA) vaccine would teach the human body to recognize these spikes, allowing the body to produce ...

Moderna’s move to merge technology and human resources into a single function is the latest sign that artificial intelligence is bringing big changes to the workforce. The biotech company late ...

Moderna will combine its technology and HR departments, inspired by their increasing reliance on generative AI and ongoing OpenAI partnership. The biotech giant currently uses over 3,000 versions ...

Stockpot Videos via Shutterstock Moderna’s mRNA-based flu and covid-19 vaccine could provide the best of both worlds—if it’s actually ever approved by the Food and Drug Administration.

CAMBRIDGE, MA / ACCESS Newswire / May 8, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conference: Bernstein's 41 st Annual Strategic ...

Moderna researchers reported that the combo shot produced a stronger immune response against COVID-19 and most flu strains than the individual vaccines already on the market. The results were ...